CSS LLC/IL - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$7,483,000
+269.9%
426,054
+104.2%
0.32%
+279.8%
Q2 2021$2,023,000
+18.3%
208,653
+31.1%
0.08%
+20.0%
Q1 2021$1,710,000
-61.2%
159,108
-46.8%
0.07%
-58.3%
Q4 2020$4,403,000
+173.6%
299,324
+164.5%
0.17%
+118.2%
Q3 2020$1,609,000
+0.2%
113,185
-43.0%
0.08%
-15.4%
Q2 2020$1,606,000
+105.1%
198,600
+2.5%
0.09%
+46.8%
Q1 2020$783,000193,7690.06%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders